Hot Features
Premium
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Zeitraum:
Zeichenmodus:
| Volumen | 128 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,80 | 10:01:08 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,80 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 14 | 128 | - | 0,67 - 80,96 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 10:02:09 | 1 | US$ 0,80 | USD |
Finanzwerte APVO
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 426,77k | 533,46k | - | 0 | -17,41M | -32,64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Aptevo Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 08.5.2024 | 14:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08.5.2024 | 14:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 07.3.2024 | 14:56 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.3.2024 | 23:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.3.2024 | 22:12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.3.2024 | 22:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.3.2024 | 14:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 05.3.2024 | 14:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.2.2024 | 22:37 | Edgar (US Regulatory) | Form 8-K - Current report |
| 31.1.2024 | 00:04 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 30.1.2024 | 14:00 | Edgar (US Regulatory) | Form DEFR14A - Revised definitive proxy soliciting materials |
| 16.1.2024 | 22:15 | Edgar (US Regulatory) | Form DEFR14A - Revised definitive proxy soliciting materials |
Forum Aptevo Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
APVO Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,91 | 0,91 | 0,78 | 0,8103888 | 202.564 | -0,11 | -12,09% |
| 1 Monat | 0,711 | 1,38 | 0,67 | 1,06 | 1.968.351 | 0,089 | 12,52% |
| 3 Monate | 6,424 | 10,80 | 0,67 | 2,17 | 1.041.265 | -5,62 | -87,55% |
| 6 Monate | 9,108 | 10,80 | 0,67 | 3,62 | 678.871 | -8,31 | -91,22% |
| 1 Jahr | 75,24 | 80,96 | 0,67 | 10,66 | 534.702 | -74,44 | -98,94% |
| 3 Jahre | 1.109,68 | 1.397,44 | 0,67 | 392,10 | 581.546 | -1.108,88 | -99,93% |
| 5 Jahre | 35,64 | 2.640,00 | 0,67 | 410,98 | 578.912 | -34,84 | -97,76% |
